These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2190015)

  • 1. Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infection.
    Takemoto Y; Kanamaru A; Nagai K; Masaoka T; Kitani T; Horiuchi A; Yonezawa T; Yasunaga K; Kageyama T; Tatsumi N
    Jpn J Antibiot; 1990 Jan; 43(1):63-9. PubMed ID: 2190015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A; Takaku F; Mizoguchi H; Nomura T; Aoki N; Yamaguchi H; Mutoh Y; Miura Y; Toyama K; Hirashima K
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
    Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Inazawa J; Abe T
    Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology].
    Chimura T; Satou S; Funayama T; Oono T; Sakai Y; Morisaki N; Kanasugi H; Takahashi H; Saitou N; Miyata R
    Jpn J Antibiot; 1991 Mar; 44(3):337-44. PubMed ID: 1880915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
    Toyama K; Yaguchi M; Mizoguchi H; Masuda M; Urabe A; Ikeda Y; Aoki I; Shinbo T; Togawa A; Hirashima K; Miura Y; Hirose S; Tsuruoka N; Omine M; Kamakura M; Saito T; Arimori S; Aoki N; Kuraishi Y; Hirai H; Asano S; Mori M; Shirai T; Muto Y; Takaku F
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1242-53. PubMed ID: 9011117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
    Shimazaki C; Inaba T; Murakami S; Oku N; Itoh K; Ura Y; Nakagawa M; Fujita N
    Jpn J Antibiot; 1990 Aug; 43(8):1402-6. PubMed ID: 2283708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
    Barboza E; del Castillo M; Yi A; Gotuzzo E
    Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
    Sakata Y; Sawada Y; Kuroe K; Nakaji S; Takami H; Tsushima K; Saito S; Ogasawara H; Shinagawa H; Soma N
    Jpn J Antibiot; 1992 Aug; 45(8):1009-15. PubMed ID: 1433889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Demirkaya M; Celebi S; Sevinir B; Hacımustafaoglu M
    Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
    Hirayama F; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Okamoto Y; Yonezawa T
    Jpn J Antibiot; 1985 Sep; 38(9):2402-12. PubMed ID: 4079014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
    Sampi K; Hattori M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1315-20. PubMed ID: 1503486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
    Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
    Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.